Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP445599.RA8sNVaB9uoh6B4bmMYVI8kBvGdJXiasbrRljlCqrrvOg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP445599.RA8sNVaB9uoh6B4bmMYVI8kBvGdJXiasbrRljlCqrrvOg130_assertion type Assertion NP445599.RA8sNVaB9uoh6B4bmMYVI8kBvGdJXiasbrRljlCqrrvOg130_head.
- NP445599.RA8sNVaB9uoh6B4bmMYVI8kBvGdJXiasbrRljlCqrrvOg130_assertion description "[Patients with a history of cardiovascular disease had significantly elevated MBL levels independent of nephropathy status (3,178 microg/l [IQR 636-5,231 microg/l] vs. 1,741 microg/l [656-3,149 microg/l], P = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP445599.RA8sNVaB9uoh6B4bmMYVI8kBvGdJXiasbrRljlCqrrvOg130_provenance.
- NP445599.RA8sNVaB9uoh6B4bmMYVI8kBvGdJXiasbrRljlCqrrvOg130_assertion evidence source_evidence_literature NP445599.RA8sNVaB9uoh6B4bmMYVI8kBvGdJXiasbrRljlCqrrvOg130_provenance.
- NP445599.RA8sNVaB9uoh6B4bmMYVI8kBvGdJXiasbrRljlCqrrvOg130_assertion SIO_000772 15161763 NP445599.RA8sNVaB9uoh6B4bmMYVI8kBvGdJXiasbrRljlCqrrvOg130_provenance.
- NP445599.RA8sNVaB9uoh6B4bmMYVI8kBvGdJXiasbrRljlCqrrvOg130_assertion wasDerivedFrom befree-2016 NP445599.RA8sNVaB9uoh6B4bmMYVI8kBvGdJXiasbrRljlCqrrvOg130_provenance.
- NP445599.RA8sNVaB9uoh6B4bmMYVI8kBvGdJXiasbrRljlCqrrvOg130_assertion wasGeneratedBy ECO_0000203 NP445599.RA8sNVaB9uoh6B4bmMYVI8kBvGdJXiasbrRljlCqrrvOg130_provenance.